Cutler Group’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,380
Closed -$3K 3884
2022
Q4
$3K Sell
12,380
-4,630
-27% -$85.4K ﹤0.01% 3441
2022
Q3
$5K Sell
17,010
-6,040
-26% -$183K ﹤0.01% 3623
2022
Q2
$15K Buy
23,050
+10,280
+81% +$835K ﹤0.01% 2888
2022
Q1
$158K Sell
12,770
-4,010
-24% -$240K 0.01% 1357
2021
Q4
$10K Sell
16,780
-19,410
-54% -$1.24M ﹤0.01% 3676
2021
Q3
$92K Buy
36,190
+22,580
+166% +$1.82M ﹤0.01% 1978
2021
Q2
$36K Buy
13,610
+1,160
+9% +$118K ﹤0.01% 2763
2021
Q1
$57K Buy
+12,450
New +$1.28M ﹤0.01% 2247

Other funds holding CELU

Cutler Group's CELU Position: Q1 2023 in Review

Cutler Group sold out of Celularity (CELU) in Q1 2023, closing a stake of 20 shares — an estimated $161 sold.

Cutler Group first reported a position in CELU in Q1 2021 and held it in 7 quarters. The position peaked at $279K in Q1 2021. 61 funds tracked by Wall St. Rank hold CELU as of Q1 2023.

  • Cutler Group reported no remaining Celularity position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 20 Celularity shares in Q1 2023, an estimated $161.
  • Cutler Group first reported a position in Celularity in Q1 2021 and held it in 7 quarters.
  • Cutler Group's Celularity position peaked at $279K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Celularity as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.